MCID and 2mg/kg x 2 dosage is now critical to ensuring both primary end points are met with a clear margin.
Should be interesting month or 2 ahead with potential trifecta of news.
The share price is unlikely to gravitate around PARO exercise if positive outcomes from agencies IMO.
The (Painful) Competition, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 25.5¢ | 23.5¢ | $152.0K | 624.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 77555 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 5801 | 8 |
View Market Depth
| Last trade - 15.42pm 27/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |